US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,578.03

-21.2968-1.33%

Number of Gainers:- -

Number of Losers:7

Number of Flat:- -

PE:- -

High:1,598.74

Open:1,598.63

Low:1,570.99

Close:1,599.33

Volume:60.92M

Turnover:5.19B

Market Cap:1.64T

Float Cap:1.58T

Loading ...

Pfizer says Phase 2 study of tilrekimig met primary endpoint

Pfizer Says Tilrekimig Hits Phase 2 Atopic Dermatitis Endpoint with 62.5% EASI-75 at Week 16

Pfizer - no Serious Adverse Events Related to Tilrekimig in Phase 2 Study

THOMSON REUTERS

Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study

THOMSON REUTERS

Pfizer - Tilrekimig Well-Tolerated with Teae Rates Comparable to Placebo

THOMSON REUTERS

Pfizer - 62.5% of Patients on Tilrekimig 450 Mg Q2w Achieve Easi-75 vs 19.9% Placebo

THOMSON REUTERS

Pfizer - Phase 2 Study Meets Primary Endpoint with Significant Easi-75 Improvement at Week 16

THOMSON REUTERS

The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind

Eli Lilly Says Foundayo Drug Helped Patients Lose Weight in Phase 3 Trial

Eli Lilly’s Foundayo shows cardiovascular safety in type 2 diabetes study

Lilly's Oral Glp-1, Foundayo (Orforglipron), Demonstrated Cardiovascular Safety Alongside Sustained A1c Reduction and Weight Loss in Its Largest and Longest Type 2 Diabetes Study

THOMSON REUTERS

Eli Lilly - Achieve-4: Foundayo Shows 16% Lower Mace-4 and 23% Lower Mace-3 Risk vs Insulin Glargine

THOMSON REUTERS

Eli Lilly - Foundayo Shows Smaller Egrf Reduction and Greater Albuminuria Reduction vs Insulin Glargine

THOMSON REUTERS

NYSE Most Active Issues

Moderately bullish activity in Novo Nordisk with shares down 1.06%

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Sector Update: Healthcare

MT Newswires Live

Novo Nordisk Opens a New Front in Cardiometabolic Care With Early-Stage Anti-Inflammatory Study

Novo Nordisk Tests Cagrisema Switch Strategy to Strengthen Its Diabetes Franchise

Lilly’s Clazakizumab Trial Pushes Cardiovascular Inflammation Strategy Forward

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BK4599/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1578.0306,"timestamp":1790884799999,"preClose":1599.3274,"halted":0,"volume":60917668,"delay":0,"changeRate":-0.013316,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-21.296753,"latestTime":"10-01 16:00:00 EDT","open":1598.6295,"high":1598.7406,"low":1570.989,"amount":5186254214.808758,"amplitude":0.017352,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790928000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.755512,"peRate":28.697452,"turnoverRate":0.005727,"increases":0,"decrements":7,"flats":0,"marketCap":1639390683648,"floatMarketCap":1581749142656},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1598.7406,"amplitude":0.017352,"preClose":1599.3274,"low":1570.989,"pbRate":"9.755512","latestPrice":1578.0306,"volume":60917668,"delay":0,"open":1598.6295,"prevYearClose":1494.5856,"prevWeekClose":1622.7886,"prevMonthClose":1599.3274,"prevQuarterClose":1599.3274,"fiveDayClose":1615.961,"twentyDayClose":1646.5784,"sixtyDayClose":1638.9335,"secType":"PLATE","market":"US","turnoverRate":0.005727,"peRate":28.697452,"marketCap":1639390683648,"floatMarketCap":1581749142656,"timestamp":1790884799999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":0,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672756456","title":"Pfizer says Phase 2 study of tilrekimig met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2672756456","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672756456?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:10","pubTimestamp":1790849423,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) presented detailed results from an ongoing Phase 2 study investigating tilrekimig in adults with moderate-to-severe atopic dermatitis....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pfizer-says-phase-2-study-of-tilrekimig-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pfizer-says-phase-2-study-of-tilrekimig-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BLSP4239.USD","LU1883839398.USD","IE00BLSP4452.SGD","LU1057294990.SGD","BK4592","LU0058720904.USD","LU0225284248.USD","LU0456855351.SGD","SG9999002232.USD","SG9999013999.USD","BK4588","LU0170899867.USD","SG9999001176.SGD","LU0321505439.SGD","IE000M9KFDE8.USD","BK4581","IE0002270589.USD","IE00B19Z3B42.SGD","LU0234572021.USD","PFE","LU0321505868.SGD","LU1066051498.USD","LU0868494617.USD","LU1066053197.SGD","LU2596442595.SGD","IE00B19Z3581.USD","BK4599","SG9999011175.SGD","SG9999001176.USD","LU1894683348.USD","BK4585","SG9999002224.SGD","LU0225771236.USD","IE00B3T34201.USD","LU0306807586.USD","OZEM","SGXZ57979304.SGD","LU0985481810.HKD","BK4007","LU0289739699.SGD","BK4534","LU1894683264.USD","IE00BBT3K403.USD","SG9999003800.SGD","BK4550","LU0122379950.USD","LU1023059063.AUD","BK4533","BK4568","LU0306806265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672375367","title":"Pfizer Says Tilrekimig Hits Phase 2 Atopic Dermatitis Endpoint with 62.5% EASI-75 at Week 16","url":"https://stock-news.laohu8.com/highlight/detail?id=2672375367","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672375367?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:31","pubTimestamp":1790836262,"startTime":"0","endTime":"0","summary":"Pfizer says tilrekimig hits Phase 2 atopic dermatitis endpoint with 62.5% EASI-75 at week 16Pfizer presented Phase 2 results for tilrekimig in moderate-to-severe atopic dermatitis at the EADV congress","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL9zmvR2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","LU2596442595.SGD","LU1066053197.SGD","IE0002270589.USD","LU0321505439.SGD","IE000M9KFDE8.USD","SG9999002224.SGD","BK4568","LU0289739699.SGD","IE00B19Z3B42.SGD","LU0306806265.USD","LU1883839398.USD","LU0170899867.USD","LU0058720904.USD","LU1894683348.USD","OZEM","BK4599","BK4007","PFE","SG9999003800.SGD","BK4592","LU0868494617.USD","BK4534","IE00B3T34201.USD","IE00BLSP4239.USD","LU1023059063.AUD","LU0321505868.SGD","LU1066051498.USD","IE00BBT3K403.USD","LU0306807586.USD","BK4581","BK4550","LU0985481810.HKD","LU0225284248.USD","SG9999001176.SGD","BK4588","LU0225771236.USD","SGXZ57979304.SGD","IE00BLSP4452.SGD","LU0122379950.USD","SG9999001176.USD","SG9999013999.USD","IE00B19Z3581.USD","BK4585","SG9999002232.USD","LU0234572021.USD","SG9999011175.SGD","LU1894683264.USD","LU1057294990.SGD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672573738","title":"Pfizer - no Serious Adverse Events Related to Tilrekimig in Phase 2 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672573738","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672573738?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PFE","BK4007","LU0321505439.SGD","OZEM","BK4534","SG9999013999.USD","LU2596442595.SGD","LU0456855351.SGD","LU0306806265.USD","BK4588","LU1066051498.USD","BK4581","IE000M9KFDE8.USD","SG9999011175.SGD","BK4585","IE0002270589.USD","IE00BLSP4239.USD","LU0234572021.USD","BK4568","LU1883839398.USD","SGXZ57979304.SGD","LU0225284248.USD","LU1894683264.USD","IE00BBT3K403.USD","LU1066053197.SGD","IE00B19Z3581.USD","LU0225771236.USD","SG9999002232.USD","LU1057294990.SGD","LU0868494617.USD","BK4592","LU0289739699.SGD","SG9999003800.SGD","BK4550","LU1894683348.USD","LU0985481810.HKD","BK4533","LU0306807586.USD","SG9999001176.USD","IE00B3T34201.USD","LU0058720904.USD","IE00BLSP4452.SGD","SG9999002224.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","BK4599","LU0321505868.SGD","SG9999001176.SGD","LU0170899867.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672382737","title":"Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672382737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672382737?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4533","LU0122379950.USD","LU0170899867.USD","LU2596442595.SGD","LU1894683264.USD","LU0289739699.SGD","LU1066051498.USD","LU1066053197.SGD","LU0306806265.USD","LU0306807586.USD","LU0868494617.USD","SG9999011175.SGD","BK4592","IE00B19Z3581.USD","IE0002270589.USD","IE000M9KFDE8.USD","LU0456855351.SGD","LU0225771236.USD","IE00BLSP4239.USD","PFE","LU0234572021.USD","IE00BBT3K403.USD","LU1057294990.SGD","BK4585","IE00B3T34201.USD","BK4007","LU0321505868.SGD","BK4534","SG9999003800.SGD","LU0058720904.USD","SG9999002224.SGD","SGXZ57979304.SGD","LU0985481810.HKD","OZEM","BK4599","BK4588","IE00B19Z3B42.SGD","SG9999001176.USD","BK4568","IE00BLSP4452.SGD","LU0321505439.SGD","SG9999001176.SGD","BK4550","LU0225284248.USD","BK4581","LU1023059063.AUD","SG9999013999.USD","SG9999002232.USD","LU1883839398.USD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672338737","title":"Pfizer - Tilrekimig Well-Tolerated with Teae Rates Comparable to Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2672338737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672338737?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0170899867.USD","LU1883839398.USD","LU1894683348.USD","BK4585","IE000M9KFDE8.USD","BK4599","LU0321505868.SGD","LU0225771236.USD","LU0306807586.USD","SG9999011175.SGD","OZEM","IE00BLSP4452.SGD","SG9999002224.SGD","BK4581","LU1894683264.USD","LU0985481810.HKD","LU0306806265.USD","IE00B19Z3581.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","LU2596442595.SGD","IE00B3T34201.USD","BK4550","LU0234572021.USD","IE0002270589.USD","LU0058720904.USD","LU0456855351.SGD","SGXZ57979304.SGD","BK4534","BK4588","PFE","LU0868494617.USD","LU1023059063.AUD","LU0122379950.USD","SG9999002232.USD","BK4592","BK4568","LU0289739699.SGD","BK4533","BK4007","LU0225284248.USD","LU1066053197.SGD","LU1057294990.SGD","LU1066051498.USD","SG9999013999.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","SG9999001176.USD","LU0321505439.SGD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672334737","title":"Pfizer - 62.5% of Patients on Tilrekimig 450 Mg Q2w Achieve Easi-75 vs 19.9% Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2672334737","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672334737?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0170899867.USD","LU1883839398.USD","LU1894683348.USD","BK4585","IE000M9KFDE8.USD","BK4599","LU0321505868.SGD","LU0225771236.USD","LU0306807586.USD","SG9999011175.SGD","OZEM","IE00BLSP4452.SGD","SG9999002224.SGD","BK4581","LU1894683264.USD","LU0985481810.HKD","LU0306806265.USD","IE00B19Z3581.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","LU2596442595.SGD","IE00B3T34201.USD","BK4550","LU0234572021.USD","IE0002270589.USD","LU0058720904.USD","LU0456855351.SGD","SGXZ57979304.SGD","BK4534","BK4588","PFE","LU0868494617.USD","LU1023059063.AUD","LU0122379950.USD","SG9999002232.USD","BK4592","BK4568","LU0289739699.SGD","BK4533","BK4007","LU0225284248.USD","LU1066053197.SGD","LU1057294990.SGD","LU1066051498.USD","SG9999013999.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","SG9999001176.USD","LU0321505439.SGD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672273733","title":"Pfizer - Phase 2 Study Meets Primary Endpoint with Significant Easi-75 Improvement at Week 16","url":"https://stock-news.laohu8.com/highlight/detail?id=2672273733","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672273733?lang=en_us&edition=fundamental","pubTime":"2026-10-01 14:30","pubTimestamp":1790836200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA30SD38:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","LU1066053197.SGD","IE00BBT3K403.USD","BK4581","LU0058720904.USD","BK4550","LU1066051498.USD","LU0234572021.USD","LU0225771236.USD","IE0002270589.USD","LU0321505439.SGD","LU0306806265.USD","LU0289739699.SGD","LU0321505868.SGD","SG9999001176.USD","SGXZ57979304.SGD","BK4568","LU1894683264.USD","LU2596442595.SGD","LU1057294990.SGD","BK4592","BK4534","IE00B19Z3581.USD","LU0306807586.USD","SG9999002224.SGD","IE00B3T34201.USD","LU1883839398.USD","OZEM","IE00B19Z3B42.SGD","SG9999011175.SGD","LU0868494617.USD","LU0456855351.SGD","LU0985481810.HKD","PFE","IE00BLSP4239.USD","SG9999013999.USD","BK4588","IE000M9KFDE8.USD","LU1894683348.USD","BK4599","SG9999003800.SGD","LU0170899867.USD","BK4585","IE00BLSP4452.SGD","LU0225284248.USD","BK4533","BK4007","SG9999001176.SGD","SG9999002232.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672273391","title":"The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind","url":"https://stock-news.laohu8.com/highlight/detail?id=2672273391","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672273391?lang=en_us&edition=fundamental","pubTime":"2026-10-01 08:00","pubTimestamp":1790812800,"startTime":"0","endTime":"0","summary":"For as long as drugmakers have been testing weight-loss drugs, the question has been: How much weight do people lose?Now it is changing to: What kind of weight are they losing?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014906.USD","IE0001KFT4U8.USD","LU0471298694.HKD","LU2023250330.USD","LU2456880835.USD","IE00BK4W5L77.USD","ELIL","LU2471134523.USD","MEDX","SGXZ81514606.USD","LU2168564222.USD","IXJ","LU0109391861.USD","LU1988902786.USD","HRTS","LU2471134952.CNY","LU2462157665.USD","LU2552382215.SGD","LU0133085943.USD","LU2271345857.HKD","TMED","LU1023059063.AUD","LU2468319806.SGD","BK4534","FHLC","LU1093756325.SGD","LU1280957306.USD","IYH","LU1868837136.USD","LU2362541273.HKD","PPH","NVOX","IBBQ","LU2023251221.USD","LU0238689110.USD","LU0466842654.USD","LU2491050071.SGD","LU0456855351.SGD","LU0114720955.EUR","LU1691799644.USD","IE00BFSS8Q28.SGD","LU1868836757.USD","LU2168563687.JPY","LU2552382058.USD","IE00BK4W5M84.HKD","LU0096364046.USD","SG9999015945.SGD","IE00B1BXHZ80.USD","LU1979441026.SGD","LLII","OZEM","SG9999015986.USD","LU0787776722.HKD","LU2461242641.AUD","LU2108987350.USD","BK4139","LU0006306889.USD","LU0345770308.USD","VHT","BK4585","LU2362541513.USD","IE00B775H168.HKD","LU1868836914.USD","LU1720051108.HKD","LU0820561909.HKD","LU0354030511.USD","IE00BJJMRX11.SGD","NVO","LU0174119429.USD","CURE","LU2112291526.USD","BBH","BK4599","LU1267930730.SGD","SG9999013999.USD","LU2237443978.SGD","LU0889565916.HKD","LU0106261372.USD","LU0210536198.USD","LU1623119135.USD","SGXZ57979304.SGD","LU0640476718.USD","LU1868836591.USD","LU2462591350.SGD","LU2896262040.SGD","RXL","LU2089283258.USD","BK4581","LU0353189763.USD","SG9999018865.SGD","LU0345770993.USD","LU0823434583.USD","LU1983299246.USD","LU1629891620.HKD","LU0158827948.USD","LU1974910355.USD","LU1064131342.USD","LU1145028129.USD","NVOC","LU0320765992.SGD","LU2361044949.HKD","IE00B7KXQ091.USD","LU2106854487.HKD","LU0672654240.SGD","LU2063271972.USD","IE00BZ1G4Q59.USD","LU1551013425.SGD","LU2756315318.SGD","LU0689472784.USD","LU1291159041.SGD","LU2602419157.SGD","IE00BJJMRZ35.SGD","ILDR","JDOC","SG9999001176.USD","LU2264538146.SGD","LU0823416689.USD","SG9999017495.SGD","IE0002141913.USD","SGXZ31699556.SGD","LU2168564149.EUR","IE00BJJMRY28.SGD","LU0820562030.AUD","SG9999018857.SGD","IE00B4JS1V06.HKD","IHE","LU2168564495.EUR","LU2237443549.SGD","LU2471134879.HKD","LLYX","TRUH","LU1035775433.USD","LU2491049909.HKD","LU1232071149.USD","IBB","IE00BJT1NW94.SGD","LU2213496289.HKD","LU0053666078.USD","LU1804176565.USD","REGN","LU2491050154.USD","IE0005OL40V9.USD","IE00BN29S564.USD","LU2552382132.HKD","SGXZ51526630.SGD","GB00BDT5M118.USD","LU2360106947.USD","LU0122379950.USD","LU2746668461.USD","LU2361045086.USD","LU0432979614.USD","LU1551013342.USD","NVOH","LU0203202063.USD","LU0256863902.USD","LU0320765059.SGD","LU0061475181.USD","SG9999015952.SGD","LU2211815571.USD","LU2362540622.SGD","TBXU","SG9999014898.SGD","MHIP","IE00BKPKM429.USD","LU2750360641.GBP","LU1366192091.USD","LU2236285917.USD","IE00B1XK9C88.USD","LU0882574139.USD","LU1093756168.USD","LU0203201768.USD","LU0964807845.USD","LU2087625088.SGD","LU2237438978.USD","IE00B2B36J28.USD","AGNG","GDOC","LU1814569148.SGD","IE0004445015.USD","LU0385154629.USD","LU2237443622.USD","LU2237443465.HKD","LU0094547139.USD","LU1548497426.USD","LU0316494557.USD","WDNA","LU1712237335.SGD","LU2746668974.SGD","CANC","IE00BFTCPJ56.SGD","LU0786609619.USD","SG9999001176.SGD","LU0820561818.USD","LU1061106388.HKD","LU0417517546.SGD","LU0256863811.USD","BK4588","LU1069344957.HKD","LLYZ","LU2028103732.USD","SG9999015978.USD","LU1868837300.USD","LU2324357040.USD","LU2471134796.USD","IE00BKDWB100.SGD","LU0353189680.USD","IE0009355771.USD","IE00BJLML261.HKD","IE00BKVL7J92.USD","ELIS","LU0109394709.USD","LU2111349929.HKD","SG9999014914.USD","LU0079474960.USD","LU0708995401.HKD","MEDI","IE0004445239.USD","LU0154236417.USD","LU0158827781.USD","LU2756315664.SGD","PJP","BK4516","LU1917777945.USD","LU0058720904.USD","LU0225283273.USD","LU0323591593.USD","LU0683600562.USD","LU0289739699.SGD","LLY","LU0823434740.USD","XLV","LU0198837287.USD","LU2237443895.HKD","LU2237443382.USD","IE00BWXC8680.SGD","IE00BFSS7M15.SGD","LU1057294990.SGD","LU1127390331.HKD","BK4007","LU2361044865.SGD","LU0097036916.USD","LU1720051017.SGD","LU2023250504.SGD","LU0234572021.USD","LU2750360997.AUD","SG9999014880.SGD","THNR","LU1323610961.USD","LU0354030438.USD","LU2168564065.EUR","IE00B4R5TH58.HKD","BK4532","LU0471298777.SGD","LU1989771016.USD","LU2265009873.SGD","LU2357305700.SGD","LU0943347566.SGD","LU0882574055.USD","LU2089984988.USD","LU0266013472.USD","LU2417539215.USD","SGXZ99366536.SGD","BK4533","LU2089284900.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672352738","title":"Eli Lilly Says Foundayo Drug Helped Patients Lose Weight in Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2672352738","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672352738?lang=en_us&edition=fundamental","pubTime":"2026-10-01 06:42","pubTimestamp":1790808120,"startTime":"0","endTime":"0","summary":"Eli Lilly's potential new weight-loss drug Foundayo had positive results in a Phase 3 trial.Foundayo, which is being studied as a treatment for obesity and Type-2 diabetes, demonstrated a non-inferior risk of major adverse cardiovascular events, compared with the alternative treatment insulin glargine.Patients treated with the drug also had improved weight and other key measures of cardiometabolic health compared with insulin glargine, the company said.The risk of cardiovascular death, heart attack, stroke or hospitalization for unstable sudden chest pain was 16% lower for Foundayo versus insulin glargine.At week 52, participants treated with Foundayo experienced reductions in waist circumference by 7 centimeters and lower systolic blood pressure.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMED","IE0004445239.USD","IE0005OL40V9.USD","SG9999014880.SGD","LU0786609619.USD","ELIL","LU1868836591.USD","ILDR","LU0058720904.USD","LU0353189680.USD","LU0787776722.HKD","LU1280957306.USD","LU1366192091.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU2746668974.SGD","LU0466842654.USD","SGXZ31699556.SGD","LU2168564149.EUR","BK4581","LU0889565916.HKD","GDOC","LU2028103732.USD","TRUH","LU1804176565.USD","LU2237438978.USD","LU0203202063.USD","LU0174119429.USD","LU0823416689.USD","LU0289739699.SGD","IE00B775H168.HKD","LU2236285917.USD","LU2361045086.USD","IE00BJJMRY28.SGD","LU2491050071.SGD","SG9999014906.USD","BK4533","SGXZ51526630.SGD","LU1057294990.SGD","LU0882574055.USD","LU2417539215.USD","LU0471298694.HKD","LU2108987350.USD","LU2756315318.SGD","LU2089283258.USD","LU2361044949.HKD","LU2471134952.CNY","LU0689472784.USD","IE00BWXC8680.SGD","BK4516","SG9999017495.SGD","BK4534","LU2168564065.EUR","SG9999015978.USD","SGXZ99366536.SGD","LU0943347566.SGD","LU2023250504.SGD","LU1623119135.USD","SG9999001176.SGD","LU1127390331.HKD","LU1232071149.USD","LU0708995401.HKD","LU2552382215.SGD","LU1988902786.USD","LU2265009873.SGD","LU2361044865.SGD","LU2112291526.USD","LU0109394709.USD","LU0354030511.USD","LU1267930730.SGD","LU0061475181.USD","MEDX","LU0096364046.USD","LU2756315664.SGD","IE00BJJMRX11.SGD","LU0203201768.USD","IE00BJLML261.HKD","LU2746668461.USD","LU1989771016.USD","LU1548497426.USD","LU0225283273.USD","IE00B7KXQ091.USD","LU2471134523.USD","LU0079474960.USD","LU1720051017.SGD","LU2461242641.AUD","IXJ","IE0009355771.USD","LU0158827948.USD","VHT","LU0256863902.USD","FHLC","FTXH","LU0672654240.SGD","LU0097036916.USD","IE00BJT1NW94.SGD","LU2471134879.HKD","LU2360106947.USD","BK4007","LU0114720955.EUR","GB00BDT5M118.USD","LU0133085943.USD","LU0345770308.USD","LU2168564222.USD","LU2462157665.USD","LU2750360997.AUD","LU0106261372.USD","LU0266013472.USD","LU2111349929.HKD","SG9999013999.USD","LU1023059063.AUD","SG9999018865.SGD","LU2552382132.HKD","LU0234572021.USD","LU2462591350.SGD","IE00BFTCPJ56.SGD","OZEM","LU2168563687.JPY","LU2237443382.USD","SG9999014898.SGD","IE00B1BXHZ80.USD","IE00BKPKM429.USD","LU0964807845.USD","LU1093756325.SGD","LU2264538146.SGD","LU0210536198.USD","PPH","LU2023250330.USD","IHE","LU2237443465.HKD","LU1061106388.HKD","LU0823434740.USD","LU1720051108.HKD","JDOC","AGNG","IE0001KFT4U8.USD","LU2468319806.SGD","LU0683600562.USD","LU1069344957.HKD","IE00B4JS1V06.HKD","LU2089984988.USD","LU0256863811.USD","LU1868837300.USD","LU2168564495.EUR","IE00BK4W5L77.USD","SG9999014914.USD","LU0820561909.HKD","LU2491049909.HKD","LU1868836914.USD","LU2211815571.USD","LU2213496289.HKD","LU1323610961.USD","SG9999018857.SGD","SGXZ57979304.SGD","LLYZ","LU0417517546.SGD","CANC","THNR","SG9999015945.SGD","LU2023251221.USD","LU1868836757.USD","LU2271345857.HKD","LU2471134796.USD","CURE","LU1629891620.HKD","LU2602419157.SGD","BK4599","LU0323591593.USD","MEDI","LLII","LU1974910355.USD","LU1064131342.USD","LU1035775433.USD","LU1712237335.SGD","LU0823434583.USD","IYH","LU0320765992.SGD","LU0432979614.USD","IE00BKDWB100.SGD","LU2357305700.SGD","ELIS","IE00BFSS8Q28.SGD","SG9999015952.SGD","LU2087625088.SGD","LU2896262040.SGD","LU1983299246.USD","LLY","LU1814569148.SGD","LU2750360641.GBP","LU1691799644.USD","LU2237443895.HKD","WDNA","PJP","LU0122379950.USD","LU0471298777.SGD","SGXZ81514606.USD","LU1291159041.SGD","LU0385154629.USD","LU0353189763.USD","LU0456855351.SGD","LU2456880835.USD","BK4585","LU1145028129.USD","LU1868837136.USD","LU1551013425.SGD","LU1093756168.USD","LU2324357040.USD","LU2552382058.USD","LU2237443549.SGD","HRTS","IE00BFSS7M15.SGD","IE00BJJMRZ35.SGD","RXL","SG9999001176.USD","IE00B2B36J28.USD","LU1551013342.USD","LU0238689110.USD","LU2491050154.USD","BK4588","LU0109391861.USD","LU1979441026.SGD","LU0198837287.USD","LU2106854487.HKD","IE0004445015.USD","LU0006306889.USD","LU0820561818.USD","LU0820562030.AUD","IE00BN29S564.USD","LU1917777945.USD","MHIP","LU0158827781.USD","LU0640476718.USD","LU2237443978.SGD","LU0354030438.USD","LU0882574139.USD","LU2089284900.SGD","IE00B1XK9C88.USD","IE00BK4W5M84.HKD","XLV","LU0316494557.USD","LLYX","LU2237443622.USD","SG9999015986.USD","LU2063271972.USD","LU0345770993.USD","LU0094547139.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672780211","title":"Eli Lilly’s Foundayo shows cardiovascular safety in type 2 diabetes study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672780211","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672780211?lang=en_us&edition=fundamental","pubTime":"2026-10-01 06:05","pubTimestamp":1790805912,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) announced detailed results from the Phase 3 ACHIEVE-4 trial evaluating the efficacy and safety of Foundayo – orforglipron – vs. tit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lillys-foundayo-shows-cardiovascular-safety-in-type-2-diabetes-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lillys-foundayo-shows-cardiovascular-safety-in-type-2-diabetes-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0096364046.USD","MEDI","IE00BKDWB100.SGD","IE00BJLML261.HKD","LU0672654240.SGD","LU1551013425.SGD","HRTS","IE0004445239.USD","LU2461242641.AUD","LU0882574139.USD","LU2462591350.SGD","LU2271345857.HKD","LU1979441026.SGD","LU2213496289.HKD","LU0203202063.USD","LU0061475181.USD","LU1720051108.HKD","LU0471298694.HKD","LU0820561818.USD","LU1323610961.USD","LU0320765059.SGD","AGNG","LU2491049909.HKD","LU2746668974.SGD","LU1366192091.USD","LU1061106388.HKD","LU1551013342.USD","LU0079474960.USD","LU2236285917.USD","LU0823434740.USD","LU2237443622.USD","LU0109394709.USD","BK4585","LU0097036916.USD","LU2471134879.HKD","MHIP","LU1291159041.SGD","LU1057294990.SGD","LU1989771016.USD","LU2361044949.HKD","LU0320765992.SGD","LU1064131342.USD","IE00BJJMRX11.SGD","BK4581","LU2417539215.USD","LU2237443895.HKD","SG9999015945.SGD","LU1983299246.USD","LU0466842654.USD","IE00BKPKM429.USD","LU2112291526.USD","LU1267930730.SGD","IYH","RXL","LU0122379950.USD","LU0354030511.USD","FTXH","LU2168564495.EUR","IXJ","LU1691799644.USD","LU2750360641.GBP","IE00B1BXHZ80.USD","SG9999015986.USD","LU2896262040.SGD","PJP","IE00B4R5TH58.HKD","IE00BJJMRY28.SGD","LU0158827781.USD","LU0689472784.USD","LU2264538146.SGD","LU0385154629.USD","LU1623119135.USD","SG9999014898.SGD","LU0823434583.USD","LU0106261372.USD","IE0002141913.USD","LU2237438978.USD","SG9999014906.USD","SGXZ99366536.SGD","LU0432979614.USD","LU2756315318.SGD","CURE","VHT","IE00B1XK9C88.USD","LU0256863902.USD","TRUH","IE0009355771.USD","LU0708995401.HKD","LU0354030438.USD","JDOC","LLYX","BK4007","LU2265009873.SGD","LU2357305700.SGD","THNR","PPH","LU1127390331.HKD","LU2168564222.USD","LU0266013472.USD","LU1868836914.USD","IE00BJJMRZ35.SGD","LU0109391861.USD","LU2361044865.SGD","BK4533","SG9999017495.SGD","LU2552382132.HKD","SGXZ31699556.SGD","SG9999018857.SGD","LU2168564065.EUR","LU0345770308.USD","IE00B7KXQ091.USD","LU0225283273.USD","BK4599","LU2746668461.USD","LU1712237335.SGD","LU0114720955.EUR","LU0889565916.HKD","LU1868837300.USD","LU2089283258.USD","IE0004445015.USD","LU0943347566.SGD","LU1093756325.SGD","LU2168563687.JPY","LU2324357040.USD","LU2471134952.CNY","IE00BFTCPJ56.SGD","LU0006306889.USD","XLV","LU1035775433.USD","LU1988902786.USD","LU0417517546.SGD","LLY","SGXZ57979304.SGD","LU2756315664.SGD","MEDX","BK4516","IE00BK4W5M84.HKD","LU0787776722.HKD","LU1093756168.USD","LU0158827948.USD","LU2491050071.SGD","LU2168564149.EUR","IE00BK4W5L77.USD","LU2106854487.HKD","LU2602419157.SGD","LU2063271972.USD","LU2456880835.USD","CANC","LU2471134523.USD","LU2750360997.AUD","LU1023059063.AUD","LU2108987350.USD","LU2462157665.USD","LU2491050154.USD","SG9999015978.USD","LU0640476718.USD","LU0823416689.USD","LU0353189763.USD","LU0471298777.SGD","LU2471134796.USD","BK4534","LU2089984988.USD","LU1280957306.USD","LU0683600562.USD","IE00BFSS7M15.SGD","LU0058720904.USD","LU1232071149.USD","LU0786609619.USD","LLYZ","LLII","LU2087625088.SGD","IE00BFSS8Q28.SGD","LU2111349929.HKD","LU2361045086.USD","ELIS","LU0210536198.USD","IE00B4JS1V06.HKD","LU0323591593.USD","IE0001KFT4U8.USD","BK4588","TMED","LU2237443978.SGD","LU1069344957.HKD","LU0238689110.USD","LU1868836591.USD","LU0133085943.USD","SGXZ81514606.USD","LU2468319806.SGD","WDNA","LU2023250504.SGD","SG9999013999.USD","LU0174119429.USD","LU0094547139.USD","GB00BDT5M118.USD","LU0203201768.USD","LU0316494557.USD","OZEM","LU2552382215.SGD","LU1720051017.SGD","LU1548497426.USD","IE00BWXC8680.SGD","LU0456855351.SGD","SG9999014914.USD","LU2211815571.USD","IE00BJT1NW94.SGD","ILDR","LU1145028129.USD","IHE","LU1814569148.SGD","LU2089284900.SGD","LU0198837287.USD","LU0820562030.AUD","SG9999001176.SGD","FHLC","LU2237443465.HKD","LU2360106947.USD","SGXZ51526630.SGD","LU1804176565.USD","IE0005OL40V9.USD","LU1629891620.HKD","LU2023250330.USD","LU0820561909.HKD","GDOC","LU2237443549.SGD","LU1868836757.USD","LU1917777945.USD","SG9999001176.USD","LU2028103732.USD","SG9999014880.SGD","LU1974910355.USD","LU0964807845.USD","SG9999018865.SGD","LU0234572021.USD","SG9999015952.SGD","IE00B2B36J28.USD","IE00B775H168.HKD","LU1868837136.USD","IE00BN29S564.USD","LU0353189680.USD","LU2552382058.USD","LU2237443382.USD","LU0345770993.USD","LU0256863811.USD","LU0289739699.SGD","LU2023251221.USD","ELIL","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672920780","title":"Lilly's Oral Glp-1, Foundayo (Orforglipron), Demonstrated Cardiovascular Safety Alongside Sustained A1c Reduction and Weight Loss in Its Largest and Longest Type 2 Diabetes Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672920780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672920780?lang=en_us&edition=fundamental","pubTime":"2026-10-01 06:00","pubTimestamp":1790805601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA572PKM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0203201768.USD","LU2213496289.HKD","SG9999014914.USD","LU1551013425.SGD","MEDX","LU2552382058.USD","BK4581","LU2106854487.HKD","IE00BK4W5L77.USD","HRTS","LU0238689110.USD","LU1061106388.HKD","LU0203202063.USD","SG9999018857.SGD","LU2271345857.HKD","LU2108987350.USD","LU0882574139.USD","LU0385154629.USD","LU1069344957.HKD","LU1267930730.SGD","IE00BN29S564.USD","LU1232071149.USD","LLYX","OZEM","LU2063271972.USD","LU1127390331.HKD","LU0354030511.USD","LU1064131342.USD","LU2168563687.JPY","LU0640476718.USD","LU2168564149.EUR","LU2237443465.HKD","LU0061475181.USD","LU2265009873.SGD","ELIS","IE00B1XK9C88.USD","LU0471298694.HKD","LU2462591350.SGD","PPH","LU2023250330.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU2756315664.SGD","LU0417517546.SGD","LU2237438978.USD","SG9999013999.USD","IE0002141913.USD","LU0786609619.USD","LU2112291526.USD","LU1868837136.USD","LU1814569148.SGD","LU2552382132.HKD","LU1712237335.SGD","FTXH","CANC","IE0004445015.USD","LU2168564222.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","SGXZ51526630.SGD","LU2491050154.USD","VHT","LU0345770993.USD","SGXZ81514606.USD","LU0345770308.USD","LU0689472784.USD","GDOC","IE00B7KXQ091.USD","SG9999015986.USD","LU1548497426.USD","LU2111349929.HKD","IE00BFSS7M15.SGD","LU0225283273.USD","LU0823434740.USD","SG9999018865.SGD","LU2324357040.USD","LU2417539215.USD","RXL","IXJ","LU2602419157.SGD","LU1280957306.USD","ELIL","LU0466842654.USD","SGXZ31699556.SGD","LLYZ","LU1691799644.USD","LU0708995401.HKD","LU2023250504.SGD","LU0256863811.USD","LU0256863902.USD","CURE","LU0672654240.SGD","LU2746668461.USD","SG9999015945.SGD","LU1093756168.USD","LU2089283258.USD","LU2023251221.USD","IE0005OL40V9.USD","LU0964807845.USD","LU0823434583.USD","LU0432979614.USD","LU1720051108.HKD","LU0058720904.USD","LU0943347566.SGD","BK4533","SG9999014906.USD","IE00BJJMRY28.SGD","LU0354030438.USD","LU1323610961.USD","LU2491050071.SGD","BK4588","LU2028103732.USD","SGXZ99366536.SGD","WDNA","LU0158827948.USD","LU0174119429.USD","LU1291159041.SGD","LU0094547139.USD","IE00BFSS8Q28.SGD","LU0471298777.SGD","LU0109394709.USD","LU1988902786.USD","TRUH","LU0198837287.USD","LU1868837300.USD","LU1366192091.USD","LU2461242641.AUD","IE00B1BXHZ80.USD","LU0210536198.USD","LU2361044865.SGD","SGXZ57979304.SGD","BK4599","LU0133085943.USD","FHLC","LU0122379950.USD","LU0114720955.EUR","LU1989771016.USD","IE00B4R5TH58.HKD","LU2360106947.USD","LU2462157665.USD","TMED","LU2237443622.USD","LU2211815571.USD","LU1623119135.USD","LU2089284900.SGD","LU2552382215.SGD","LU2361045086.USD","MHIP","IE00B2B36J28.USD","SG9999015952.SGD","SG9999001176.SGD","LU0353189763.USD","LU0096364046.USD","LU0823416689.USD","LU1979441026.SGD","PJP","IE00BWXC8680.SGD","LU0289739699.SGD","LU0316494557.USD","LU2456880835.USD","IE00BKPKM429.USD","SG9999014898.SGD","BK4534","LU2896262040.SGD","MEDI","IE0004445239.USD","LU0097036916.USD","IE00B775H168.HKD","LU2471134879.HKD","LU2471134952.CNY","LU0456855351.SGD","LU0266013472.USD","IE0009355771.USD","AGNG","LU2237443549.SGD","BK4007","GB00BDT5M118.USD","LU0079474960.USD","LU1917777945.USD","LU0006306889.USD","IE00BJJMRX11.SGD","LU1974910355.USD","LU2237443895.HKD","LU2491049909.HKD","LU1868836591.USD","LU2264538146.SGD","IE0001KFT4U8.USD","LLII","LU0323591593.USD","LU2087625088.SGD","LU0882574055.USD","IE00BK4W5M84.HKD","IHE","LU2471134796.USD","LU0106261372.USD","LU0109391861.USD","LU0320765992.SGD","LU0820562030.AUD","LU0889565916.HKD","LU2089984988.USD","BK4585","LU0320765059.SGD","ILDR","LU1023059063.AUD","LU2357305700.SGD","LU0158827781.USD","LU2750360641.GBP","LU1629891620.HKD","THNR","LU0683600562.USD","LU2746668974.SGD","SG9999001176.USD","LU1551013342.USD","SG9999015978.USD","LU2236285917.USD","LU2756315318.SGD","LU2168564495.EUR","XLV","IE00BJLML261.HKD","SG9999017495.SGD","LU0820561909.HKD","BK4516","JDOC","LLY","LU0820561818.USD","LU1145028129.USD","LU1804176565.USD","IYH","IE00BKDWB100.SGD","LU2237443382.USD","LU0234572021.USD","LU2471134523.USD","SG9999014880.SGD","LU0353189680.USD","LU1035775433.USD","LU1057294990.SGD","LU1720051017.SGD","LU1983299246.USD","LU2361044949.HKD","LU2750360997.AUD","LU2237443978.SGD","IE00B4JS1V06.HKD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU0787776722.HKD","LU2168564065.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672809787","title":"Eli Lilly - Achieve-4: Foundayo Shows 16% Lower Mace-4 and 23% Lower Mace-3 Risk vs Insulin Glargine","url":"https://stock-news.laohu8.com/highlight/detail?id=2672809787","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672809787?lang=en_us&edition=fundamental","pubTime":"2026-10-01 06:00","pubTimestamp":1790805601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA572PKM:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LLII","LU1989771016.USD","LU1868837300.USD","SG9999018857.SGD","LU0823434583.USD","LU2468319806.SGD","BK4585","LU1145028129.USD","IE0001KFT4U8.USD","BK4588","IE00B7KXQ091.USD","ELIS","LU2108987350.USD","LU0354030511.USD","IE00BJJMRZ35.SGD","LU0823434740.USD","LU1868836914.USD","SG9999014914.USD","GDOC","LU0061475181.USD","LU2471134879.HKD","LU0889565916.HKD","LU2361044865.SGD","LU2746668974.SGD","LU1023059063.AUD","LU0203202063.USD","SG9999013999.USD","LU0320765059.SGD","LU0466842654.USD","LU1720051017.SGD","OZEM","LU2089284900.SGD","LU2491050154.USD","SGXZ51526630.SGD","SG9999018865.SGD","LU0079474960.USD","IE0002141913.USD","JDOC","LU1061106388.HKD","IXJ","IE00BJJMRX11.SGD","LU0225283273.USD","LU2111349929.HKD","LU2168563687.JPY","LU1712237335.SGD","LU1814569148.SGD","LU2456880835.USD","LU2106854487.HKD","PPH","LU1366192091.USD","LU2023250504.SGD","BK4599","VHT","LU0471298777.SGD","AGNG","LU2237443622.USD","LU0109394709.USD","LU2168564222.USD","LU2168564495.EUR","LU2462591350.SGD","IE0009355771.USD","LU0094547139.USD","IE00BKDWB100.SGD","SG9999017495.SGD","FHLC","LU2471134796.USD","IE0005OL40V9.USD","LU2552382215.SGD","LU1868837136.USD","MHIP","LU0683600562.USD","LU1974910355.USD","LU0096364046.USD","CURE","SGXZ57979304.SGD","LU0786609619.USD","IE00BFSS8Q28.SGD","BK4581","LU0787776722.HKD","LU1868836591.USD","LU0058720904.USD","LLYZ","LU0174119429.USD","LU2168564149.EUR","IE00BJJMRY28.SGD","LU2265009873.SGD","LU2471134952.CNY","XLV","LU0133085943.USD","LU2360106947.USD","LU0882574055.USD","HRTS","TMED","IE0004445015.USD","LU0689472784.USD","IE0004445239.USD","LU0256863811.USD","LU0672654240.SGD","SG9999014906.USD","SGXZ81514606.USD","LU0820561818.USD","LU2324357040.USD","LU2063271972.USD","LU0823416689.USD","LU0353189680.USD","IE00B1XK9C88.USD","RXL","PJP","SG9999001176.USD","LU0345770308.USD","SG9999014880.SGD","LU0266013472.USD","LU0456855351.SGD","LU2168564065.EUR","LU2750360641.GBP","LU1551013342.USD","GB00BDT5M118.USD","LU2461242641.AUD","LU2471134523.USD","LU0203201768.USD","LU1069344957.HKD","LU2756315664.SGD","LU1323610961.USD","LU0882574139.USD","IE00BFSS7M15.SGD","LU0198837287.USD","LU0943347566.SGD","LU0471298694.HKD","LU0234572021.USD","LU2361044949.HKD","LU0006306889.USD","LU0353189763.USD","LU1868836757.USD","LU1232071149.USD","LU2089984988.USD","BK4534","LU1057294990.SGD","LU2491050071.SGD","LU2896262040.SGD","LU2023250330.USD","LU0964807845.USD","LU0320765992.SGD","LU2237443549.SGD","MEDX","LU1720051108.HKD","LU2746668461.USD","LU0354030438.USD","IE00BFTCPJ56.SGD","LU0708995401.HKD","LU2236285917.USD","LU0385154629.USD","LU0158827781.USD","IHE","LU1267930730.SGD","SG9999001176.SGD","LU0417517546.SGD","LU0106261372.USD","LU2417539215.USD","TRUH","ILDR","SGXZ99366536.SGD","LU0345770993.USD","LU0820562030.AUD","SG9999015986.USD","LU1623119135.USD","LU2491049909.HKD","IE00BK4W5M84.HKD","CANC","LU1551013425.SGD","LU0640476718.USD","LU2237443978.SGD","WDNA","IE00BJT1NW94.SGD","SGXZ31699556.SGD","LU1064131342.USD","LU0109391861.USD","LU2112291526.USD","LU2361045086.USD","LU2750360997.AUD","LU2462157665.USD","LU2211815571.USD","LU0114720955.EUR","IE00BWXC8680.SGD","SG9999015978.USD","LU0238689110.USD","SG9999014898.SGD","LU0256863902.USD","LU2213496289.HKD","LU2237443382.USD","IYH","LU0122379950.USD","LU1127390331.HKD","LU2028103732.USD","IE00B2B36J28.USD","LU2089283258.USD","FTXH","LU1093756168.USD","BK4533","LU2271345857.HKD","LU0316494557.USD","IE00B4JS1V06.HKD","LU2087625088.SGD","LU1548497426.USD","SG9999015945.SGD","LU0210536198.USD","LU1291159041.SGD","BK4516","LLY","IE00BK4W5L77.USD","LU0432979614.USD","BK4007","LU1691799644.USD","LU2023251221.USD","LU2602419157.SGD","IE00BN29S564.USD","MEDI","IE00BJLML261.HKD","LU0158827948.USD","LU1035775433.USD","LU0097036916.USD","LU1804176565.USD","LLYX","THNR","LU2237443895.HKD","IE00BKPKM429.USD","LU2756315318.SGD","LU2237443465.HKD","IE00B4R5TH58.HKD","LU2237438978.USD","LU2264538146.SGD","LU0289739699.SGD","LU1988902786.USD","LU1629891620.HKD","LU1983299246.USD","LU1093756325.SGD","SG9999015952.SGD","LU1979441026.SGD","IE00B1BXHZ80.USD","LU2552382058.USD","LU2552382132.HKD","LU2357305700.SGD","IE00B775H168.HKD","LU1280957306.USD","LU0323591593.USD","LU1917777945.USD","ELIL","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672780927","title":"Eli Lilly - Foundayo Shows Smaller Egrf Reduction and Greater Albuminuria Reduction vs Insulin Glargine","url":"https://stock-news.laohu8.com/highlight/detail?id=2672780927","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672780927?lang=en_us&edition=fundamental","pubTime":"2026-10-01 06:00","pubTimestamp":1790805601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA572PKM:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","IE00B2B36J28.USD","LU0823434583.USD","LU0316494557.USD","LU0256863902.USD","LU0109394709.USD","IE00BFSS8Q28.SGD","IE00BN29S564.USD","LU0225283273.USD","LU2089283258.USD","LU2211815571.USD","LU0640476718.USD","LU1814569148.SGD","LU2168563687.JPY","LU2271345857.HKD","LU0109391861.USD","LU2023251221.USD","SG9999014898.SGD","LU2471134952.CNY","CURE","LU2750360641.GBP","LU0353189680.USD","LU0823434740.USD","LU0122379950.USD","ELIS","LU0820561818.USD","SG9999018865.SGD","LU0094547139.USD","SG9999013999.USD","LU2168564495.EUR","IE00B775H168.HKD","IE00BFSS7M15.SGD","VHT","LU0079474960.USD","IYH","LU2746668461.USD","LU2756315318.SGD","LU1868836591.USD","LU2087625088.SGD","LU2168564065.EUR","BK4585","LU0006306889.USD","LU0353189763.USD","LU0354030511.USD","LU1979441026.SGD","LU2462157665.USD","IE0001KFT4U8.USD","LU1917777945.USD","LU1035775433.USD","LU2063271972.USD","IE00BJT1NW94.SGD","LU1366192091.USD","IE00B4R5TH58.HKD","ILDR","LU0256863811.USD","BK4581","SG9999018857.SGD","SGXZ31699556.SGD","LLYX","LU1548497426.USD","LU2552382132.HKD","WDNA","LU1323610961.USD","LU2896262040.SGD","FHLC","LU1145028129.USD","LU0203202063.USD","IE00BJLML261.HKD","LU0097036916.USD","SG9999001176.USD","LU0471298777.SGD","LU1720051017.SGD","LU2602419157.SGD","LU2552382058.USD","IE00BKDWB100.SGD","LU1974910355.USD","LU1291159041.SGD","LU2023250330.USD","LU0266013472.USD","LU2023250504.SGD","LLII","LU2111349929.HKD","LU2746668974.SGD","LU0823416689.USD","IXJ","LU0889565916.HKD","LU0964807845.USD","PPH","LU0417517546.SGD","IE00B4JS1V06.HKD","LU0203201768.USD","LLYZ","MEDX","LU0345770308.USD","LU0689472784.USD","LU2456880835.USD","PJP","LU2491050154.USD","LU1868837136.USD","LU1983299246.USD","LU1093756325.SGD","BK4533","LU1551013342.USD","RXL","LU0289739699.SGD","LU0787776722.HKD","THNR","IE00BKPKM429.USD","IE0004445239.USD","LU1064131342.USD","IE00BJJMRY28.SGD","LU0106261372.USD","LU0323591593.USD","LU1232071149.USD","LU2237443978.SGD","HRTS","LU0320765992.SGD","IE00BK4W5L77.USD","LU2756315664.SGD","SG9999001176.SGD","LU2028103732.USD","LU1061106388.HKD","LU1551013425.SGD","ELIL","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU0943347566.SGD","LU1868836914.USD","IE00BK4W5M84.HKD","LU1804176565.USD","MHIP","LU2264538146.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0471298694.HKD","LU2361045086.USD","LU0096364046.USD","LU1720051108.HKD","LU0385154629.USD","LU0882574139.USD","IE0005OL40V9.USD","LU2361044949.HKD","LU2237438978.USD","SG9999014906.USD","JDOC","BK4599","SGXZ99366536.SGD","LU2461242641.AUD","BK4534","LU2324357040.USD","LU2112291526.USD","BK4588","BK4007","LU2750360997.AUD","LU1127390331.HKD","LU2106854487.HKD","LU2236285917.USD","IE00BJJMRX11.SGD","LU0320765059.SGD","IE0004445015.USD","LU1629891620.HKD","CANC","LU0158827948.USD","LU0238689110.USD","LU0345770993.USD","LU1868836757.USD","LU1691799644.USD","SGXZ81514606.USD","LU2468319806.SGD","IE00B7KXQ091.USD","LU0672654240.SGD","BK4516","LU0882574055.USD","TRUH","LU0466842654.USD","LU0786609619.USD","IE00B1BXHZ80.USD","LU1280957306.USD","LU2089984988.USD","LU2237443622.USD","LU0820562030.AUD","LU1712237335.SGD","LU1093756168.USD","LU0114720955.EUR","LU0058720904.USD","LU2213496289.HKD","LU1988902786.USD","LU2491049909.HKD","AGNG","SG9999015986.USD","TMED","LU2168564222.USD","SGXZ51526630.SGD","LU0158827781.USD","LU0234572021.USD","LU0061475181.USD","LU0174119429.USD","LU0354030438.USD","LU2237443465.HKD","LU1057294990.SGD","LU2237443549.SGD","SG9999015978.USD","LU1989771016.USD","LU2471134523.USD","LU0820561909.HKD","LU1267930730.SGD","LU0133085943.USD","SG9999014880.SGD","IE0002141913.USD","LU2108987350.USD","IE00BJJMRZ35.SGD","LU2168564149.EUR","LU2417539215.USD","LU0198837287.USD","LU2471134796.USD","SG9999015945.SGD","LU0210536198.USD","LU2491050071.SGD","IE00B1XK9C88.USD","LU2237443382.USD","LLY","GDOC","IE00BWXC8680.SGD","LU2462591350.SGD","SGXZ57979304.SGD","XLV","LU2089284900.SGD","LU2360106947.USD","SG9999014914.USD","GB00BDT5M118.USD","LU2237443895.HKD","MEDI","LU2357305700.SGD","LU2471134879.HKD","SG9999017495.SGD","LU2265009873.SGD","LU0683600562.USD","LU0708995401.HKD","LU0432979614.USD","LU1623119135.USD","OZEM","SG9999015952.SGD","LU1868837300.USD","LU1023059063.AUD","IHE","LU2552382215.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672806357","title":"NYSE Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2672806357","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672806357?lang=en_us&edition=fundamental","pubTime":"2026-10-01 05:44","pubTimestamp":1790804640,"startTime":"0","endTime":"0","summary":"Nu Holdings Cl A              NU   103,843,945     12.66     0.31      2.51. Itau Unibanco ADR           ITUB    54,094,719      8.53     0.44      5.44. Nike Cl B                    NKE    37,851,584     35.40    -0.44     -1.23. Bank of America              BAC    33,021,490     54.43    -0.53     -0.96. Hewlett Packard Ent          HPE    32,706,194     63.89     2.40      3.90","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE","BK4007","DINT","APIE","LU0321505439.SGD","OZEM","DIVL","LU1804176565.USD","LU1363072403.SGD","TFNS","BK4505","KBWB","AADR","LU0130102774.USD","FTXO","PATH","LU2129689605.HKD","XLF","BK4585","IE0002270589.USD","LU0477156797.USD","IE00BLSP4239.USD","LU0234572021.USD","LU0314106906.USD","LU0208291251.USD","PATX","LU0477156953.USD","IYG","SGXZ57979304.SGD","LU1074936037.SGD","LU1894683264.USD","LU1861558580.USD","VFH","LU1057294990.SGD","LU2133065610.SGD","FNCL","LU1366192091.USD","BAC","UYG","LU0149725797.USD","SAPH","CVY","LU1894683348.USD","LU0070302665.USD","LU0256863811.USD","ARMH","LU1201861249.SGD","BK4599","IYF","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672787943","title":"Moderately bullish activity in Novo Nordisk with shares down 1.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2672787943","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672787943?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:45","pubTimestamp":1790801124,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Novo Nordisk (NVO), with shares down 40c near $37.91. Options volume roughly in line with average with 54k contracts...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-down-1-06-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-down-1-06-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NVOC","LU1093756325.SGD","BK4599","IE00BKVL7J92.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","NVO","NVOX","OZEM","PPH","THNR","BK4588","BK4532","NVOH","BK4007","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782095","title":"Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782095","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782095?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:36","pubTimestamp":1790800560,"startTime":"0","endTime":"0","summary":"DJ Abbott Laboratories Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Abbott Laboratories  slid 2.10% to $98.83 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,651.54 and Dow Jones Industrial Average  falling 0.86% to 50,906.05.This was the stock's third consecutive day of losses.Abbott Laboratories closed 27.04% short of its 52-week high of $135.45, which the company reached on October 1st.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 1.06% to $264.74, Pfizer Inc.  fell 0.70% to $28.52, and Merck & Co. Inc.  fell 2.66% to $145.31.Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1929549753.HKD","LU1585245621.USD","LU1069347547.HKD","LU1057294990.SGD","LU1261432733.SGD","LU1699723380.USD","LU2211815571.USD","LU1093756168.USD","LU0266013472.USD","LU0456855351.SGD","IE0009355771.USD","LU2125154778.USD","LU1934455277.USD","LU2213496289.HKD","IE00BBT3K403.USD","BK4504","LU0795875169.SGD","IE000M9KFDE8.USD","LU1244550577.SGD","BK4082","PPH","LU2430703178.SGD","LU0289739343.SGD","LU0162691827.USD","LU0238689110.USD","LU2125154935.USD","LU0225284248.USD","LU1201861249.SGD","BK4532","MRK","LU1551013425.SGD","IE00BVYPNV92.GBP","LU1116320901.HKD","IE00BN8TJ469.HKD","LU0321505439.SGD","LU2756315664.SGD","IE00BJJMRZ35.SGD","LU0648001328.SGD","LU0069063385.USD","LU0057025933.USD","MEDX","IE0000B7K699.USD","IE00BLSP4452.SGD","LU0861579265.USD","LU0265550359.USD","OZEM","IE00BKVL7J92.USD","LU1023059063.AUD","SG9999014559.SGD","LU0795875086.SGD","LU1732799900.SGD","LU1989771016.USD","LU0965509283.SGD","LU1983299246.USD","LU0170899867.USD","BK4599","LU0053666078.USD","LU1989763690.USD","LU0949170772.SGD","SGXZ57979304.SGD","SG9999003800.SGD","LU1162221912.USD","BK4588","LU1228905037.USD","LU0823416689.USD","LU0820561818.USD","LU1228905540.USD","LU0640476718.USD","VHT","IE00B1BXHZ80.USD","LU1989772840.SGD","LU1196500208.SGD","LU0130102774.USD","LU0070217475.USD","SG9999004303.SGD","LU0820561909.HKD","LU0868494617.USD","LU2491050071.SGD","LU2491049909.HKD","LU0072461881.USD","LU2491050154.USD","JNJ","LU1629891620.HKD","BK4559","LU0320765646.SGD","LU1691799644.USD","LU0289961442.SGD","SG9999013999.USD","LU1043141123.HKD","LU1145028129.USD","LU0980610538.SGD","LU1037948897.HKD","LU2106854487.HKD","LU2403377893.USD","IE00B42XCP33.USD","LU1066051498.USD","IE000WAW04H5.SGD","LU0098860793.USD","LU2129689514.USD","IE0001KFT4U8.USD","LU2750360997.AUD","LU1035773651.USD","IE000F7OJYX1.SGD","LU0942090050.USD","BK4007","BK4568","LU2750360641.GBP","LU2357627491.SGD","RXL","SG9999002224.SGD","LU0225771236.USD","LU1221951046.USD","LU0210528500.USD","SG9999011175.SGD","LU1267930813.SGD","LU1670627923.USD","BK4566","BK4592","LU0124676726.USD","ABT","LU2471134796.USD","LU2361045086.USD","SGXZ80539844.SGD","IE00B19Z3B42.SGD","IE00BGHQF631.EUR","LU0868494708.USD","LU2324357040.USD","SGXZ23171101.USD","LU2347655156.SGD","LU0234572021.USD","LU0203345920.USD","LU0345769631.USD","LU1061106388.HKD","SG9999015358.SGD","SG9999001440.SGD","PJP","LU1721429741.USD","LU2360032135.SGD","LU1244550494.USD","LU0432979614.USD","LU0208291251.USD","LU0306807586.USD","LU1941712348.USD","FTXH","IE000SO60NU8.SGD","IE0002141913.USD","LU1121112475.USD","LU0472753341.HKD","IE00B2B36J28.USD","LU0689472784.USD","LU1093756325.SGD","LU2237957811.SGD","LU1059921491.USD","LU2023250330.USD","LU1914381329.SGD","BK4516","LU1551013342.USD","LU1074936037.SGD","LU0943347566.SGD","LU0882574055.USD","LU0234570918.USD","LU0553294199.USD","LU1043141396.HKD","SG9999014542.SGD","BK4550","LU0070302665.USD","LU1496350502.SGD","LU2505996681.GBP","LU0106261372.USD","LU2471134879.HKD","LU1674673691.USD","LU1934455863.HKD","BK4581","LU0661504455.SGD","LU0058720904.USD","BMED","IE0002270589.USD","HRTS","LU1923622614.USD","SG9999001176.USD","LU1778281490.HKD","XLV","SG9999001176.SGD","LU2129689431.USD","LU1221951129.SGD","LU1935042991.SGD","LU0738911758.USD","IE00B4R5TH58.HKD","LU0965509101.SGD","IHE","LU2023250504.SGD","LU2471134523.USD","LU0345769128.USD","LU0859254822.USD","LU1974910355.USD","LU2133065610.SGD","BK4533","IE00BZ1G4Q59.USD","GDOC","LU1894683348.USD","LU0787776722.HKD","LU1941712264.USD","LU1032466523.USD","LU2361044949.HKD","LU1721429402.USD","LU0211331839.USD","LU0210536198.USD","IE00B7SZLL34.SGD","IYH","LU0122379950.USD","LU0545039389.USD","LU1116320737.USD","LU1732800096.USD","IE00BJT1NW94.SGD","LU1066053197.SGD","IE0034235303.USD","LU2430703095.HKD","LU2430703251.USD","TRUH","IE000BZT7R73.USD","IE00B3T34201.USD","LU2592432038.USD","JDOC","BK4534","LU1989772923.USD","IE00B19Z3581.USD","LU2125909247.SGD","LU2461242641.AUD","LU0345770993.USD","LU0320765489.SGD","IE00BVYPNW00.USD","TMED","LU0511384066.AUD","LU2487616109.SGD","PAWZ","IE00B3PB1722.GBP","LU1066051225.USD","LU0130517989.USD","FHLC","LU2468319806.SGD","IXJ","LU0545562505.USD","IE000MB6IJN5.SGD","LU0345770308.USD","PFE","LU2112291526.USD","LU2125909593.SGD","LU1917777945.USD","LU2433249047.HKD","LU0994945656.USD","LU2471134952.CNY","LU0964807845.USD","IE00BFXG1179.USD","LU0289739699.SGD","LU1934455194.USD","LU1280957306.USD","LU0426417589.USD","LU0912757837.SGD","SG9999002232.USD","SGXZ41872573.SGD","LU1003077747.HKD","LU0306806265.USD","LU1883839398.USD","LU1674673428.USD","SG9999015341.SGD","LU0965509010.AUD","LU1989763427.SGD","LU2505996509.AUD","LU0792757196.USD","LU1430594728.SGD","LU2129689605.HKD","LU0985320562.USD","IE00BLSP4239.USD","LU0114720955.EUR","LU1032955483.USD","IE00BFTCPJ56.SGD","LU0889566641.SGD","LU1291159041.SGD","LU1718418525.SGD","LU0321505868.SGD","LU2361044865.SGD","LU0426412945.USD","LU0689626769.HKD","LU2602419157.SGD","LU0203347892.USD","LU1066051811.HKD","LU1244550221.USD","LU0985481810.HKD","LU1506573853.SGD","LU1894683264.USD","IE00BDGV0183.EUR","LU2756315318.SGD","LU2456880835.USD","SG9999014575.USD","LU0265550946.USD","LU1571399168.USD","BK4585","LU2596442595.SGD","IHI","SG9999014567.USD","LU0683600562.USD","LU2896262040.SGD","LU0477156953.USD","LU0006306889.USD","LU2236285917.USD","LU0466842654.USD","LU1670628061.USD","LU1037948541.HKD","LU2089984988.USD","IE00BSNM7G36.USD","LU2417539215.USD","LU0820562030.AUD","LU2237957902.USD","LU2023250843.SGD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672789918","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672789918","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672789918?lang=en_us&edition=fundamental","pubTime":"2026-10-01 01:08","pubTimestamp":1790788105,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Wednesday afternoon, with the NYSE Healthcare Index down 0.4% and the State Street Health Care Select Sector SPDR ETF  shedding 0.3%.The iShares Biotechnology ETF  rose 0.4%.In corporate news, Eli Lilly  on Wednesday reported positive results from a phase 2b trial of its investigational combination of eloralintide and tirzepatide in 367 obese or overweight adults with type 2 diabetes. All combinations of EloraTZP met the primary and secondary endpoints at 48 weeks, delivering \"substantial\" weight loss and A1C reduction, the company said. Lilly shares were up 0.2%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BK4W5M84.HKD","IBB","LU1064131342.USD","LU1057294990.SGD","LU0345770993.USD","LABU","LU2456880835.USD","LU0943347566.SGD","LU0354030438.USD","LU0820561909.HKD","LU0234572021.USD","SG9999018865.SGD","GDOC","LU0114720955.EUR","LU0964807845.USD","LU2023250330.USD","LU2746668974.SGD","LU2236285917.USD","LU2361045086.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU0094547139.USD","BK4007","LU0456855351.SGD","SGXZ51526630.SGD","ILDR","LU1868837300.USD","LU0672654240.SGD","LU0128526141.USD","LLYZ","LU0466842654.USD","LU2213496289.HKD","LU2361044949.HKD","LU0320765992.SGD","LU2746668461.USD","GB00BDT5M118.USD","LU1093756168.USD","SG9999015952.SGD","BK4581","LU0029874061.USD","SG9999018857.SGD","WDNA","LU2471134523.USD","LLY","LU2552382132.HKD","LU1035775433.USD","BK4534","IXJ","LU2361044865.SGD","SG9999014914.USD","LU1061106388.HKD","OZEM","LU2552382215.SGD","LU0708995401.HKD","LU1974910355.USD","IE0005OL40V9.USD","BK4533","LU0266013472.USD","LU0882574055.USD","LU2750360641.GBP","HRTS","LU2168564065.EUR","LU1989771016.USD","SG9999014880.SGD","CURE","LU1868836591.USD","LU1548497426.USD","IE00BFSS8Q28.SGD","LU0096364046.USD","LU0198837287.USD","IE00BKPKM429.USD","LU0385154629.USD","LU2063271972.USD","LU0689472784.USD","LU2089284900.SGD","IE00BN29S564.USD","XLV","LU1291159041.SGD","IE00BFSS7M15.SGD","LU0256863902.USD","AGNG","HCSG","IE0001KFT4U8.USD","LU2168563687.JPY","LU2756315318.SGD","IE00B1XK9C88.USD","SG9999001176.SGD","IE00BK4W5L77.USD","ELIS","IE0004445239.USD","LU0061475181.USD","BK4588","LU1868836757.USD","LU2023251221.USD","SGXZ81514606.USD","LU0058720904.USD","TMED","LU0353189680.USD","LU2271345857.HKD","LU0225283273.USD","LU0320765059.SGD","SG9999017495.SGD","LU0432979614.USD","LU2461242641.AUD","LU2896262040.SGD","BK4599","LU1551013342.USD","LU1280957306.USD","LU0787776722.HKD","LU0353189763.USD","LU0106261372.USD","LU1629891620.HKD","LU2237438978.USD","IE00BWXC8680.SGD","LU0323591593.USD","IE00B7KXQ091.USD","LU1814569148.SGD","LU1712237335.SGD","SG9999014906.USD","IE00BJJMRY28.SGD","IYH","LU0471298694.HKD","LU2750360997.AUD","LU0823434740.USD","LU0640476718.USD","LU1127390331.HKD","LU2089283258.USD","RXL","SGXZ57979304.SGD","LU0316494557.USD","LU2168564222.USD","LU2237443622.USD","XBI","SGXZ31699556.SGD","LU2491050071.SGD","TRUH","LU0109394709.USD","LU2264538146.SGD","LU0210536198.USD","LU0354030511.USD","LU1868836914.USD","LU2089984988.USD","LU2357305700.SGD","LU2462157665.USD","CANC","LU0882574139.USD","LU1979441026.SGD","LU2211815571.USD","IE00B4JS1V06.HKD","IE0004445015.USD","LU1093756325.SGD","LLYX","IE00B775H168.HKD","IE00BKDWB100.SGD","SGXZ99366536.SGD","ELIL","LU1023059063.AUD","LU1983299246.USD","LU1623119135.USD","SG9999001176.USD","SG9999014898.SGD","LU1366192091.USD","LU0889565916.HKD","LU0158827781.USD","LU0174119429.USD","FTXH","LU1069344957.HKD","LU2112291526.USD","MEDI","SG9999013999.USD","LU2756315664.SGD","LU2111349929.HKD","LU0203201768.USD","BK4585","LU0256863811.USD","LU1232071149.USD","LU2491049909.HKD","LU0097036916.USD","LU2471134796.USD","LU0823434583.USD","PPH","LU0109391861.USD","IE00BJLML261.HKD","LU0345770308.USD","LU2237443465.HKD","LU2237443895.HKD","LU0820561818.USD","LU2237443978.SGD","LU1323610961.USD","SG9999015978.USD","IE0002141913.USD","LU2106854487.HKD","LU0823416689.USD","IHE","IE00BJJMRZ35.SGD","LU0471298777.SGD","LU2087625088.SGD","LU2168564495.EUR","MEDX","LU2028103732.USD","LU0203202063.USD","LU0683600562.USD","LLII","LU0158827948.USD","LU2491050154.USD","LU2602419157.SGD","LU1917777945.USD","LU2417539215.USD","LU1720051017.SGD","LU0820562030.AUD","LU1267930730.SGD","JDOC","IE00BJT1NW94.SGD","LU2237443382.USD","LU2265009873.SGD","THNR","LU2168564149.EUR","LU2552382058.USD","LU0122379950.USD","LU1145028129.USD","VHT","LU2237443549.SGD","PJP","LU0133085943.USD","LU0238689110.USD","LU1691799644.USD","IE00BJJMRX11.SGD","LU0417517546.SGD","LU1988902786.USD","LU0289739699.SGD","LU2324357040.USD","SG9999015945.SGD","LU1551013425.SGD","IE0009355771.USD","LU2023250504.SGD","LU2108987350.USD","LU2471134879.HKD","IE00B1BXHZ80.USD","FHLC","IE00B4R5TH58.HKD","BK4137","LU0079474960.USD","LU1804176565.USD","LU1868837136.USD","LU0006306889.USD","LU2462591350.SGD","MHIP","SG9999015986.USD","LU1720051108.HKD","LU2471134952.CNY","BK4516","IE00BFTCPJ56.SGD","LU2360106947.USD","LU0786609619.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672700786","title":"Novo Nordisk Opens a New Front in Cardiometabolic Care With Early-Stage Anti-Inflammatory Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672700786","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672700786?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:31","pubTimestamp":1790785892,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk Explores New Anti-Inflammatory Pathway for Heart and Metaboli...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-opens-a-new-front-in-cardiometabolic-care-with-early-stage-anti-inflammatory-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-opens-a-new-front-in-cardiometabolic-care-with-early-stage-anti-inflammatory-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOH","THNR","BK4532","LU0154236417.USD","IE00BKVL7J92.USD","NVO","BK4599","NVOX","OZEM","BK4588","NVOC","LU1093756168.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","PPH","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672778609","title":"Novo Nordisk Tests Cagrisema Switch Strategy to Strengthen Its Diabetes Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2672778609","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672778609?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:31","pubTimestamp":1790785861,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk Studies Key Switch From Ozempic to Cagrisema for Type 2 Diabe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-tests-cagrisema-switch-strategy-to-strengthen-its-diabetes-franchise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-tests-cagrisema-switch-strategy-to-strengthen-its-diabetes-franchise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","BK4532","IE00BKVL7J92.USD","BK4588","BK4585","LU1093756168.USD","NVO","NVOC","BK4007","NVOH","OZEM","THNR","NVOX","LU1093756325.SGD","BK4599","IE00BZ1G4Q59.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672786047","title":"Lilly’s Clazakizumab Trial Pushes Cardiovascular Inflammation Strategy Forward","url":"https://stock-news.laohu8.com/highlight/detail?id=2672786047","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672786047?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:30","pubTimestamp":1790785853,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly And Company (LLY) is running a Phase 2b study called “A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lillys-clazakizumab-trial-pushes-cardiovascular-inflammation-strategy-forward?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lillys-clazakizumab-trial-pushes-cardiovascular-inflammation-strategy-forward?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","LU2468319806.SGD","SG9999015986.USD","LU0823434583.USD","IE00B775H168.HKD","IXJ","AGNG","LU1712237335.SGD","SG9999015945.SGD","LU0345770308.USD","LU1691799644.USD","LU1057294990.SGD","SG9999015952.SGD","SG9999013999.USD","IE00B1XK9C88.USD","LU0061475181.USD","LU2211815571.USD","SGXZ81514606.USD","IE00BJJMRY28.SGD","LU1145028129.USD","LU1323610961.USD","IE00BK4W5M84.HKD","LU2112291526.USD","LU0106261372.USD","LU0256863811.USD","LU1917777945.USD","LU2462591350.SGD","LU2106854487.HKD","LU2471134879.HKD","LU1093756168.USD","BK4581","SG9999014880.SGD","LU1988902786.USD","LU0266013472.USD","LU2168564149.EUR","LU2265009873.SGD","LU0058720904.USD","LU0456855351.SGD","LU0316494557.USD","LU0256863902.USD","IE0009355771.USD","LU2237443465.HKD","LU2237443382.USD","HRTS","LU2213496289.HKD","IE00B7KXQ091.USD","LLYX","LU2237443978.SGD","LU1127390331.HKD","SG9999017495.SGD","IE0001KFT4U8.USD","LU0471298694.HKD","LU2471134952.CNY","LU0964807845.USD","ELIL","SG9999018857.SGD","LU2750360997.AUD","LU0289739699.SGD","LU2108987350.USD","SG9999001176.USD","LU1280957306.USD","LU0158827948.USD","LU0672654240.SGD","PPH","SG9999001176.SGD","XLV","LU0097036916.USD","IE00BFSS8Q28.SGD","LU1868836914.USD","LU2552382058.USD","LU0238689110.USD","LU1720051108.HKD","SGXZ31699556.SGD","IE00BKPKM429.USD","LU0198837287.USD","LU0353189680.USD","LU0354030438.USD","LU1551013425.SGD","BK4007","LU0889565916.HKD","IE00B4R5TH58.HKD","LU1069344957.HKD","IHE","LU2023250504.SGD","LU2471134523.USD","LU0786609619.USD","IE00BN29S564.USD","LU2750360641.GBP","LU1868836757.USD","LU0203201768.USD","LU0385154629.USD","LU2360106947.USD","LU2756315664.SGD","IE00BJJMRZ35.SGD","LU2089284900.SGD","LU0079474960.USD","LU2552382215.SGD","LU0158827781.USD","RXL","LU2552382132.HKD","LU0323591593.USD","LU1974910355.USD","SG9999018865.SGD","LU2168564222.USD","LU1623119135.USD","BK4533","MEDX","LU0225283273.USD","GDOC","LU2089283258.USD","ILDR","LU1232071149.USD","LU1979441026.SGD","LU2063271972.USD","LU2746668974.SGD","LLII","LU1804176565.USD","LU0320765992.SGD","LU1814569148.SGD","LU0114720955.EUR","IE00BFTCPJ56.SGD","LU0787776722.HKD","LU1291159041.SGD","IE00BK4W5L77.USD","LU1064131342.USD","LU2023251221.USD","OZEM","LU1023059063.AUD","LLYZ","CURE","LU1868836591.USD","LU2462157665.USD","LU2471134796.USD","LU1035775433.USD","LLY","LU1989771016.USD","LU2361044949.HKD","LU2361045086.USD","SG9999015978.USD","SGXZ51526630.SGD","LU2361044865.SGD","LU0471298777.SGD","SGXZ99366536.SGD","LU2491049909.HKD","LU2602419157.SGD","LU0320765059.SGD","LU1983299246.USD","LU1366192091.USD","BK4599","IE0005OL40V9.USD","LU0210536198.USD","IE0004445015.USD","IYH","LU2028103732.USD","LU0122379950.USD","LU2324357040.USD","LU1548497426.USD","LU0174119429.USD","LU0234572021.USD","LU0109394709.USD","IE00BJLML261.HKD","LU2168563687.JPY","LU0353189763.USD","IE00BJT1NW94.SGD","LU0882574139.USD","SGXZ57979304.SGD","LU2357305700.SGD","LU2237443622.USD","LU1061106388.HKD","BK4588","PJP","LU2756315318.SGD","LU0823416689.USD","TRUH","LU0820561818.USD","IE00BWXC8680.SGD","LU0354030511.USD","LU0432979614.USD","LU2456880835.USD","WDNA","BK4585","LU2237443895.HKD","JDOC","LU0094547139.USD","IE00BFSS7M15.SGD","LU0683600562.USD","BK4534","LU0823434740.USD","LU2237438978.USD","SG9999014914.USD","LU0640476718.USD","FTXH","LU2896262040.SGD","MEDI","VHT","IE00B1BXHZ80.USD","LU2264538146.SGD","LU1629891620.HKD","LU2271345857.HKD","LU2168564065.EUR","LU2461242641.AUD","LU0006306889.USD","IE0004445239.USD","LU0345770993.USD","THNR","LU0417517546.SGD","IE0002141913.USD","LU2236285917.USD","LU0466842654.USD","LU2237443549.SGD","ELIS","IE00B4JS1V06.HKD","LU1868837300.USD","LU0820561909.HKD","IE00B2B36J28.USD","LU0689472784.USD","LU2746668461.USD","TMED","LU1093756325.SGD","SG9999014898.SGD","LU2087625088.SGD","LU2089984988.USD","LU0203202063.USD","IE00BKDWB100.SGD","LU2491050071.SGD","GB00BDT5M118.USD","LU0708995401.HKD","LU2023250330.USD","LU2417539215.USD","LU0133085943.USD","CANC","LU0820562030.AUD","LU2111349929.HKD","BK4516","IE00BJJMRX11.SGD","LU1720051017.SGD","LU2491050154.USD","MHIP","LU1551013342.USD","SG9999014906.USD","LU1267930730.SGD","LU0109391861.USD","LU2168564495.EUR","LU0096364046.USD","LU1868837136.USD","LU0943347566.SGD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":2,"totalSize":283,"code":"91000000","status":"200"}]}}